Skip to main content
Erschienen in: Current Oncology Reports 12/2019

01.12.2019 | Palliative Medicine (A Jatoi, Section Editor)

The Role of Ablation in Cancer Pain Relief

verfasst von: Dimitrios K. Filippiadis, Steven Yevich, Frederic Deschamps, Jack W. Jennings, Sean Tutton, Alexis Kelekis

Erschienen in: Current Oncology Reports | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The purpose of this article is to describe the concepts of ablation techniques for pain relief in symptomatic oncologic patients. Controversies concerning techniques and products will be addressed.

Recent Findings

Despite conventional pain palliative techniques, cancer patients often endorse unresolved somatic and neuropathic pain that can present as a great burden to quality of life. In non-operative patients, several techniques have been applied to minimize opioid dependence. While radiotherapy is often considered as a non-invasive option, percutaneous ablation has been advanced as a minimally-invasive alternative with clear procedural and outcome advantages. Similar to radiation therapy, percutaneous ablation techniques can act either upon nerve structures responsible for pain mediation signals (neurolysis) or directly upon the tumor to relieve tumor-mediated inflammation and decompress tumor compression of adjacent structures.

Summary

Percutaneous ablation provides valuable neurolysis and tumor-directed pain palliative effects to be incorporated into clinical guidelines for pain reduction in oncologic patients. Selection among different ablation techniques should be based upon an individually tailored approach, to include consideration of all treatment modalities.
Literatur
1.
Zurück zum Zitat • Filippiadis DK, Tselikas L, Tsitskari M, Kelekis A, de Baere T, Ryan AG. Percutaneous Neurolysis for Pain Management in Oncological Patients. Cardiovasc Intervent Radiol. 2019;42(6):791–9. https://doi.org/10.1007/s00270-019-02185-x Recent multi-centered review providing details as well as tips and tricks for all kinds of percutaneous neurolysis techniques. CrossRefPubMed • Filippiadis DK, Tselikas L, Tsitskari M, Kelekis A, de Baere T, Ryan AG. Percutaneous Neurolysis for Pain Management in Oncological Patients. Cardiovasc Intervent Radiol. 2019;42(6):791–9. https://​doi.​org/​10.​1007/​s00270-019-02185-x Recent multi-centered review providing details as well as tips and tricks for all kinds of percutaneous neurolysis techniques. CrossRefPubMed
4.
Zurück zum Zitat Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997;69:1–18.CrossRef Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997;69:1–18.CrossRef
5.
Zurück zum Zitat • Moynagh MR, Kurup AN, Callstrom MR. Thermal Ablation of Bone Metastases. Semin Interv Radiol. 2018;35(4):299–308. https://doi.org/10.1055/s-0038-1673422 Review providing details as well as tips and tricks for all kinds of percutaneous ablation techniques for osseous metastatic disease. CrossRef • Moynagh MR, Kurup AN, Callstrom MR. Thermal Ablation of Bone Metastases. Semin Interv Radiol. 2018;35(4):299–308. https://​doi.​org/​10.​1055/​s-0038-1673422 Review providing details as well as tips and tricks for all kinds of percutaneous ablation techniques for osseous metastatic disease. CrossRef
6.
Zurück zum Zitat WHO. Cancer pain relief: with a guide to opioid availability. 2nd ed. 1996. http://apps.who. int/iris/bitstream/10665/37896/1/9241544821.pdf. WHO. Cancer pain relief: with a guide to opioid availability. 2nd ed. 1996. http://​apps.​who. int/iris/bitstream/10665/37896/1/9241544821.pdf.
24.
Zurück zum Zitat Kastler B, Michalakis D, Clair CH, Allal R, Delabrousse E, Peireira PH, et al. Stellate ganglion radiofrequency neurolysis under CT guidance. Preliminary study. JBR-BTR. 2001;84(5):191–4.PubMed Kastler B, Michalakis D, Clair CH, Allal R, Delabrousse E, Peireira PH, et al. Stellate ganglion radiofrequency neurolysis under CT guidance. Preliminary study. JBR-BTR. 2001;84(5):191–4.PubMed
25.
Zurück zum Zitat Amr SA, Reyad RM, Othman AH, Mohamad MF, Mostafa MM, Alieldin NH, et al. Comparison between radiofrequency ablation and chemical neurolysis of thoracic splanchnic nerves for the management of abdominal cancer pain randomized trial. Eur J Pain. 2018;2(10):1782–90. https://doi.org/10.1002/ejp.1274. CrossRef Amr SA, Reyad RM, Othman AH, Mohamad MF, Mostafa MM, Alieldin NH, et al. Comparison between radiofrequency ablation and chemical neurolysis of thoracic splanchnic nerves for the management of abdominal cancer pain randomized trial. Eur J Pain. 2018;2(10):1782–90. https://​doi.​org/​10.​1002/​ejp.​1274.​ CrossRef
31.
Zurück zum Zitat Hol PK, Kvarstein G, Viken O, Smedby O, Tonnessen TI. MRI-guided celiac plexus block. J Magn Reson Imaging. 2000;12(4):562–4.CrossRef Hol PK, Kvarstein G, Viken O, Smedby O, Tonnessen TI. MRI-guided celiac plexus block. J Magn Reson Imaging. 2000;12(4):562–4.CrossRef
33.
Zurück zum Zitat Haynsworth RF Jr, Noe CE. Percutaneous lumbar sympathectomy: a comparison of radiofrequency denervation versus phenol neurolysis. Anesthesiology. 1991;74(3):459–63.CrossRef Haynsworth RF Jr, Noe CE. Percutaneous lumbar sympathectomy: a comparison of radiofrequency denervation versus phenol neurolysis. Anesthesiology. 1991;74(3):459–63.CrossRef
34.
Zurück zum Zitat Trescot AM. Cryoanalgesia in interventional pain management. Pain Physician. 2003;6(3):345–60.PubMed Trescot AM. Cryoanalgesia in interventional pain management. Pain Physician. 2003;6(3):345–60.PubMed
35.
Zurück zum Zitat Kawamata M, Ishitani K, Ishikawa K, Sasaki H, Ota K, Omote K, et al. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain. 1996;64(3):597–602.CrossRef Kawamata M, Ishitani K, Ishikawa K, Sasaki H, Ota K, Omote K, et al. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain. 1996;64(3):597–602.CrossRef
41.
Zurück zum Zitat • Kurup AN, Schmit GD, Morris JM, Atwell TD, Schmitz JJ, Weisbrod AJ, et al. Avoiding complications in bone and soft tissue ablation. Cardiovasc Intervent Radiol. 2017;40(2):166–76. https://doi.org/10.1007/s00270-016-1487-y Recent review providing details as well as tips and tricks for avoiding complications during bone ablation. CrossRefPubMed • Kurup AN, Schmit GD, Morris JM, Atwell TD, Schmitz JJ, Weisbrod AJ, et al. Avoiding complications in bone and soft tissue ablation. Cardiovasc Intervent Radiol. 2017;40(2):166–76. https://​doi.​org/​10.​1007/​s00270-016-1487-y Recent review providing details as well as tips and tricks for avoiding complications during bone ablation. CrossRefPubMed
43.
47.
Zurück zum Zitat Coupal TM, Pennycooke K, Mallinson PI, Ouellette HA, Clarkson PW, Hawley P, et al. The hopeless case? Palliative Cryoablation and Cementoplasty procedures for palliation of large pelvic bone metastases. Pain Physician. 2017;20(7):E1053–61.PubMed Coupal TM, Pennycooke K, Mallinson PI, Ouellette HA, Clarkson PW, Hawley P, et al. The hopeless case? Palliative Cryoablation and Cementoplasty procedures for palliation of large pelvic bone metastases. Pain Physician. 2017;20(7):E1053–61.PubMed
56.
Zurück zum Zitat Greenwood TJ, Wallace A, Friedman MV, Hillen TJ, Robinson CG, Jennings JW. Combined ablation and radiation therapy of spinal metastases: a novel multimodality treatment approach. Pain Physician. 2015;18(6):573–81.PubMed Greenwood TJ, Wallace A, Friedman MV, Hillen TJ, Robinson CG, Jennings JW. Combined ablation and radiation therapy of spinal metastases: a novel multimodality treatment approach. Pain Physician. 2015;18(6):573–81.PubMed
58.
Zurück zum Zitat • Di Staso M, Zugaro L, Gravina GL, Bonfili P, Marampon F, Di Nicola L, et al. A feasibility study of percutaneous Radiofrequency Ablation followed by Radiotherapy in the management of painful osteolytic bone metastases. Eur Radiol. 2011;21(9):2004–10. https://doi.org/10.1007/s00330-011-2133-3 Feasibility study reporting significantly better results concerning pain reduction when combined approaches (Radiotherapy and ablation) are applied. CrossRefPubMed • Di Staso M, Zugaro L, Gravina GL, Bonfili P, Marampon F, Di Nicola L, et al. A feasibility study of percutaneous Radiofrequency Ablation followed by Radiotherapy in the management of painful osteolytic bone metastases. Eur Radiol. 2011;21(9):2004–10. https://​doi.​org/​10.​1007/​s00330-011-2133-3 Feasibility study reporting significantly better results concerning pain reduction when combined approaches (Radiotherapy and ablation) are applied. CrossRefPubMed
Metadaten
Titel
The Role of Ablation in Cancer Pain Relief
verfasst von
Dimitrios K. Filippiadis
Steven Yevich
Frederic Deschamps
Jack W. Jennings
Sean Tutton
Alexis Kelekis
Publikationsdatum
01.12.2019
Verlag
Springer US
Erschienen in
Current Oncology Reports / Ausgabe 12/2019
Print ISSN: 1523-3790
Elektronische ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-019-0844-9

Weitere Artikel der Ausgabe 12/2019

Current Oncology Reports 12/2019 Zur Ausgabe

Melanoma (RJ Sullivan, Section Editor)

Primary Melanoma: from History to Actual Debates

Breast Cancer (B Overmoyer, Section Editor)

PI3K Inhibitors in Breast Cancer Therapy

Melanoma (RJ Sullivan, Section Editor)

The Evolution of Adjuvant Therapy for Melanoma

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.